ESC Congress 24 – Day 2 of the ESC Congress 2024 was packed with important data for cardiovascular practice. 

Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) joined us to summarise the key take-home messages from hot line trials presented on day.

Day 2 Highlights:

00:24-03:02: NOTION-3: Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

03:03-06:49: RHEIA: Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

06:55-08:50: POPular PAUSE TAVI: Continuation or interruption of oral anticoagulation during TAVI?

08:51-11:07: MATTERHORN: Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

11:08-15:47: RESHAPE-HF2: Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

15:48-18:50: TRI.Fr: Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation 

18:51-21:15: ASSURE DES: Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery

21:16-22:54: SWEDEGRAFT: No-touch vein grafts in coronary artery bypass grafting

Watch the Day 1 ESC 24 wrap-up from Dr Alasnag and Dr Al-Shaibi here.

Recorded on-site at the ESC Congress 2024, London.

Editors: Mirjam Boros and Jordan Rance.
Video Specialists: Dan Brent, Tom Green, Mike Knight, Oliver Miles, David Ben-Harosh.
Support: This is an independent discussion produced by Radcliffe Cardiology.